(:SPNE)

Dec 27, 2022 04:05 pm ET
SeaSpine Announces 100th Placement of 7D FLASH™ Navigation System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the placement of its 100th 7D FLASH™ Navigation System globally. The 7D FLASH™...
Nov 30, 2022 11:10 am ET
SEASPINE HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SeaSpine Holdings Corporation - SPNE
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of SeaSpine Holdings Corporation (NasdaqGS: SPNE) with Orthofix Medical Inc. (NasdaqGS: OFIX). Under the terms of the proposed transaction, shareholders of SeaSpine will receive only 0.4163 shares of Orthofix for each share of SeaSpine that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Nov 18, 2022 07:00 am ET
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing
Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic will serve as Chief Financial Officer (CFO) for the new combined company, effective upon the completion of their pending merger.
Nov 18, 2022 07:00 am ET
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing
Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that...
Nov 17, 2022 04:48 pm ET
EQUITY ALERT: The M&A Class Action Firm Continues Investigating the Merger -SPNE, PEBO, SBCF, RCKT
NEW YORK, Nov. 17, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
Nov 16, 2022 09:03 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FCRD, SPNE, AKUS, LMST
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: First Eagle Alternative Capital BDC,...
Nov 15, 2022 04:32 pm ET
INVESTOR ALERT: The M&A Class Action Firm Continues Investigating the Merger –SPNE, LMST, JVA, SMBC
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Nov 15, 2022 10:00 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JVA, SLDB, FCRD, SPNE
NEW YORK, Nov. 15, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Nov 10, 2022 09:40 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JVA, SLDB, FCRD, SPNE
NEW YORK, Nov. 10, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Nov 06, 2022 01:07 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MVBF, SMBC, SPNE, SLDB
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: MVB Financial Corp. (NASDAQ: MVBF)’s...
Nov 03, 2022 02:20 pm ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) BTRS Holdings Inc. (Nasdaq – BTRS), SeaSpine Holdings Corporation (Nasdaq - SPNE), Talos Energy Inc. (NYSE - T
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Nov 02, 2022 07:00 am ET
SeaSpine to Present at the Stifel 2022 Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the upcoming Stifel 2022 Healthcare Conference....
Nov 02, 2022 05:57 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FCRD, SPNE, OFIX
NEW YORK, Nov. 2, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Nov 01, 2022 10:15 pm ET
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of SeaSpine Holdings Corp. - SPNE
NEW YORK, Nov. 1, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating SeaSpine Holdings Corp. (SPNE), relating to its proposed sale to Orthofix Medical Inc. Under the terms of the agreement, SeaSpine shareholders will own approximately 43.5% of the combined company. Click here for more information: https://w
Nov 01, 2022 04:02 pm ET
SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the third quarter of 2022. Summary Third Quarter 2022...
Oct 31, 2022 04:05 pm ET
SeaSpine Announces Full Commercial Launch of the Mariner MIS Wayfinder System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Mariner® MIS Wayfinder System.  Mariner...
Oct 31, 2022 12:47 pm ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Myovant Sciences Ltd. (NYSE - MYOV), ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SP
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Oct 30, 2022 11:28 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HVBC, SMBC, FCRD, SPNE
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: HV Bancorp, Inc. (NASDAQ: HVBC)’s sale...
Oct 28, 2022 11:15 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, AYLA, SPNE, OFIX
NEW YORK, Oct. 28, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Oct 24, 2022 07:00 am ET
SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading...
Oct 23, 2022 09:57 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates POSH, SPNE, OFIX
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Poshmark, Inc. (NASDAQ: POSH)’s sale...
Oct 20, 2022 10:45 am ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nas
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Oct 18, 2022 11:08 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ECOM, FORG, SPNE, OFIX
NEW YORK   , Oct. 18, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Oct 18, 2022 04:10 pm ET
SeaSpine Announces Full Commercial Launch of the 7D FLASH™ Navigation System Percutaneous Spine Module for Minimally Invasive Surgery
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the 7D FLASH™ Navigation System Percutaneous Spine...
Oct 16, 2022 10:06 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OIIM, SLDB, POSH, SPNE
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: O2Micro International Limited (NASDAQ:...
Oct 14, 2022 01:37 pm ET
SHAREHOLDER ALERT: Weiss Law Investigates Orthofix Medical Inc.
NEW YORK, Oct. 14, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX) in connection with the proposed acquisition of the Company by SeaSpine Holdings Corporation ("SeaSpine") (NASDAQ: SPNE).  Under the terms of the merger agreement, the Company's shareholders will receive 0.4163 shares of SeaSpine common stock for each Orthofix share owned, representing implied per-share merger consideration of approximately $2.44 based upon SeaSpine' Oc
Oct 13, 2022 01:50 pm ET
Moore Kuehn Encourages LOTZ, FORG, SPNE, and KNBE Investors to Contact Law Firm
NEW YORK, Oct. 13, 2022 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:
Oct 12, 2022 08:04 pm ET
SEASPINE HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SeaSpine Holdings Corporation - SPNE
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of SeaSpine Holdings Corporation (NasdaqGS: SPNE) with Orthofix Medical Inc. (NasdaqGS: OFIX). Under the terms of the proposed transaction, shareholders of SeaSpine will receive only 0.4163 shares of Orthofix for each share of SeaSpine that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Oct 11, 2022 01:37 pm ET
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of SeaSpine Holdings Corporation (Nasdaq - SPNE)
Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of SeaSpine Holdings Corporation (“SeaSpine” or the “Company”) (Nasdaq – SPNE) for possible breaches of fiduciary duty and other...
Oct 11, 2022 11:20 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYBE, HIL, ECOM, SPNE, OFIX
NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Oct 11, 2022 11:00 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, SPNE, OFIX
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: ForgeRock, Inc. (NYSE: FORG)’s sale to...
Oct 11, 2022 09:31 am ET
Thinking about buying stock in Acumen Pharmaceuticals, Delta Air Lines, Blue Apron, United Airlines, or SeaSpine Holdings?
NEW YORK, Oct. 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ABOS, DAL, APRN, UAL, and SPNE.
Oct 11, 2022 09:18 am ET
Shareholder Alert: Ademi LLP investigates whether SeaSpine Holdings Corporation has obtained a Fair Price in its transaction with Orthofix
MILWAUKEE, Oct. 11, 2022 /PRNewswire/ -- Ademi LLP is investigating SeaSpine (NASDAQ: SPNE) for possible breaches of fiduciary duty and other violations of law in its transaction with Orthofix. 
Oct 11, 2022 08:05 am ET
SPNE STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of SeaSpine Holdings Corporation Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of SeaSpine Holdings Corporation (NASDAQ: SPNE) to Orthofix Medical Inc. for 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock is fair to SeaSpine shareholders. Following the close of the transaction, SeaSpine shareholders will own approximately 43.5% of the combined company.
Oct 11, 2022 06:05 am ET
SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the third quarter of 2022. Preliminary and...
Oct 11, 2022 06:00 am ET
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company
Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced they...
Oct 11, 2022 06:00 am ET
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company
Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced they have entered into a definitive agreement to combine in an all-stock merger of equals.
Sep 15, 2022 04:32 pm ET
SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the company will present at the 2022 Ladenburg Thalmann Healthcare Conference on...
Sep 06, 2022 04:05 pm ET
SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the WaveForm TA (TLIF Articulating) Interbody...
Aug 18, 2022 04:30 pm ET
SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging...
Aug 02, 2022 04:05 pm ET
SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today second quarter financial results for the three-months ended June 30, 2022....
Aug 01, 2022 04:05 pm ET
SeaSpine® Announces Full Commercial Launch of Meridian™ Anterior Lumbar Interbody System Featuring Reef ™ A Interbody
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Meridian Anterior Lumbar Interbody System...
Jul 26, 2022 04:05 pm ET
SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42nd Annual Global Growth...
Jul 20, 2022 04:05 pm ET
SeaSpine to Report Second Quarter 2022 Financial Results on August 2, 2022
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading...
Jul 19, 2022 04:05 pm ET
SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit Facility
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has amended its credit facility with Wells Fargo Bank, N.A. The amendment...
Jun 21, 2022 04:05 pm ET
SeaSpine® Announces Full Commercial Launch of WaveForm® C 3D-printed Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the WaveForm C Interbody System. The...
Jun 08, 2022 04:05 pm ET
SeaSpine Announces Full Commercial Launch of the WaveForm™ TO (TLIF Oblique) 3D-Printed Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its 3D-printed WaveForm TO (TLIF Oblique) Interbody...
May 03, 2022 04:05 pm ET
SeaSpine Reports 21 Percent Revenue Growth for First Quarter 2022 and Increases Full Year 2022 Revenue Guidance
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months ended March 31, 2022. Summary First...
May 03, 2022 04:04 pm ET
SeaSpine® Announces New Senior Leadership Team Appointments
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic, previously the Company’s Senior Vice President, Chief...
May 02, 2022 04:05 pm ET
SeaSpine® Announces Full Commercial Launch of OsteoTorrent™ DBM Product Families
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of OsteoTorrent and OsteoTorrent C, both of which are...
Apr 28, 2022 04:05 pm ET
SeaSpine® Announces Full Commercial Launch of Explorer® TO Expandable Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Explorer® TO (TLIF Oblique) Expandable...
Apr 19, 2022 04:05 pm ET
SeaSpine to Report First Quarter 2022 Financial Results on May 3, 2022
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release first quarter financial results after the close of trading...
Apr 11, 2022 04:05 pm ET
SeaSpine Announces Full Commercial Launch of the Reef® TA (TLIF Articulating) Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Reef TA (TLIF Articulating) Interbody System....
Mar 24, 2022 04:05 pm ET
SeaSpine® Announces 50,000th NanoMetalene® Implantation
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the implantation of the 50,000th NanoMetalene® interbody device. NanoMetalene is...
Mar 15, 2022 09:00 am ET
SeaSpine to Participate in the Canaccord Musculoskeletal Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will participate in the Canaccord Musculoskeletal Conference on...
Mar 11, 2022 09:00 am ET
SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2021....
Mar 07, 2022 04:05 pm ET
SeaSpine® Announces New Senior Leadership Team Appointments
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the elevation of Dr. Frank Vizesi to Chief Scientific Officer and Shaeffer...
Mar 01, 2022 04:05 pm ET
SeaSpine® Announces Full Commercial Launch of NorthStar™ Facet Fusion and Limited Commercial Launch of FLASH™ Navigation Lumbar Facet Fusion
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of NorthStar™ Cervical Facet Fusion and the limited...
Feb 24, 2022 05:41 pm ET
SeaSpine to Host Virtual Analyst and Investor Day on March 11, 2022
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release fourth quarter and full year 2021 financial results on...
Jan 10, 2022 08:00 am ET
SeaSpine Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Including Record Fourth Quarter 2021 Revenue
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full year 2021. Fourth...
Dec 14, 2021 04:05 pm ET
SeaSpine Appoints Seasoned Healthcare Executive to its Board of Directors
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has appointed Angela Steinway to its Board of Directors, effective...
Nov 23, 2021 04:05 pm ET
SeaSpine Announces Full Commercial Launch of the Admiral™ ACP System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its Admiral ACP System. Admiral ACP represents the...
Nov 08, 2021 04:05 pm ET
SeaSpine to Participate in Upcoming Investor Conferences
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in upcoming virtual investor conferences. Event:...
Nov 01, 2021 04:05 pm ET
SeaSpine Announces Limited Commercial Launch of Mariner MIS Wayfinder
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of initial surgeries of the Mariner®...
Oct 28, 2021 04:05 pm ET
SeaSpine Reports Third Quarter 2021 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended September 30, 2021. Summary of...
Oct 20, 2021 04:05 pm ET
SeaSpine to Report Third Quarter 2021 Financial Results on October 28, 2021
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading...
Oct 11, 2021 04:11 pm ET
SeaSpine Announces Full Commercial Launch of The NorthStar OCT Posterior Cervical Fixation System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its NorthStar OCT Posterior Cervical Fixation...
Oct 06, 2021 04:05 pm ET
SeaSpine Announces First Cases of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the successful completion of the first cases in both the United States and...
Oct 04, 2021 04:05 pm ET
SeaSpine® Receives Innovative Technology Contract from Vizient for its 7D FLASH™ Navigation System
SeaSpine Holdings Corporation (NASDAQ: SPNE) announced its 7D FLASH Navigation System has received an Innovative Technology contract from Vizient, Inc., the nation’s largest member-driven health care performance improvement company. The contract...
Sep 27, 2021 04:05 pm ET
SeaSpine Announces CE Mark Certification of 7D Surgical Cranial Module and Percutaneous Spine Module for Minimally Invasive Spine Surgery
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it received simultaneous CE Mark certification for its Cranial Module and...
Sep 22, 2021 04:05 pm ET
SeaSpine to Participate in the Cantor Virtual Global Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Cantor Virtual Global Healthcare Conference on...
Sep 16, 2021 04:05 pm ET
SeaSpine to Host Analyst & Investor Event on September 30, 2021
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will host an Analyst & Investor Event in Boston, Massachusetts on...
Sep 09, 2021 04:03 pm ET
OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical FLASH Navigation Platform for Pediatric Applications
OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced they have entered into a distribution agreement with SeaSpine® Orthopedics...
Sep 07, 2021 04:05 pm ET
SeaSpine Announces Initial Launch of Mariner Adult Deformity System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of initial surgeries of the Mariner...
Aug 12, 2021 04:05 pm ET
SeaSpine Announces Limited Commercial Launch of the WaveForm® A (ALIF) 3D-Printed Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm A (ALIF) Interbody...
Aug 05, 2021 04:05 pm ET
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to nine non-executive employees. The awards...
Aug 02, 2021 04:05 pm ET
SeaSpine Reports Second Quarter 2021 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended June 30, 2021. Summary of Second...
Jul 28, 2021 04:05 pm ET
SeaSpine to Participate in the Canaccord Genuity 41st Annual Growth Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Canaccord Genuity 41st Annual Growth Conference...
Jul 26, 2021 04:05 pm ET
SeaSpine to Report Second Quarter 2021 Financial Results on August 2, 2021
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading...
Jul 07, 2021 04:05 pm ET
SeaSpine Announces FDA 510(k) Clearance of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the FDA 510(k) clearance of its 7D Percutaneous Spine Module for minimally...
Jul 06, 2021 09:15 am ET
CoImmune, Inc. Appoints Michael Fekete and Greg Tibbitts to its Board of Directors
CoImmune, Inc., a clinical stage immuno-oncology company that will redefine cancer treatment using best-in-class yet more affordable cellular immunotherapies, today announced the appointments of Michael Fekete and Greg Tibbitts, to the Company’s...
Jun 29, 2021 04:05 pm ET
SeaSpine to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Ladenburg Thalmann 2021 Virtual Healthcare...
Jun 08, 2021 04:05 pm ET
SeaSpine Announces Limited Commercial Launch of the WaveForm® L (Lateral) 3D-Printed Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm L (Lateral) Interbody...
Jun 04, 2021 04:05 pm ET
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to Beau Standish and 44 non-executive...
May 20, 2021 04:05 pm ET
SeaSpine Announces Closing of 7D Surgical Acquisition
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the previously announced acquisition of 7D Surgical. 7D Surgical...
May 10, 2021 04:05 pm ET
SeaSpine to Participate in the Canaccord Genuity Virtual Musculoskeletal Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Canaccord Genuity Virtual Musculoskeletal...
May 07, 2021 04:05 pm ET
SeaSpine Announces Change of Annual Meeting to Virtual Meeting
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that, in response to the continued public health concerns regarding in-person...
May 03, 2021 04:05 pm ET
SeaSpine Reports First Quarter 2021 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended March 31, 2021. Summary of First...
Apr 21, 2021 08:00 am ET
SeaSpine to Report First Quarter 2021 Financial Results on May 3, 2021
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release first quarter financial results after the close of trading...
Apr 19, 2021 04:05 pm ET
SeaSpine Announces Limited Commercial Launch of the WaveForm® TO (TLIF Oblique) 3D-Printed Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm TO (TLIF Oblique)...
Apr 15, 2021 09:45 pm ET
SeaSpine Prices Public Offering of Common Stock
SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced...
Apr 15, 2021 04:01 pm ET
SeaSpine Commences Public Offering of Common Stock
SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has commenced an underwritten public...
Apr 05, 2021 04:05 pm ET
SeaSpine Announces Preliminary Results for First Quarter 2021 and Increases 2021 Revenue Guidance
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the first quarter of 2021 and provided updated...
Apr 01, 2021 04:05 pm ET
SeaSpine Appoints Google Executive and Healthcare Thought Leader to its Board of Directors
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has appointed Shweta Singh Maniar to its Board of Directors, effective...
Mar 22, 2021 04:05 pm ET
SeaSpine Announces Agreement to Acquire 7D Surgical
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has entered into an agreement to acquire all of the issued and...
Mar 01, 2021 04:05 pm ET
SeaSpine Announces Fourth Quarter and Full-Year 2020 Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2020....
Mar 01, 2021 08:00 am ET
SeaSpine Announces Full Commercial Launch of the Reef™ TO (TLIF Oblique) Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Reef TO (TLIF Oblique) Interbody System. The...
Feb 22, 2021 04:05 pm ET
SeaSpine to Report Fourth Quarter 2020 Financial Results on March 1, 2021
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release fourth quarter financial results after the close of trading...
Feb 22, 2021 08:00 am ET
SeaSpine Announces Limited Commercial Launch of WaveForm™ TA (TLIF Articulating) 3D-Printed Interbody System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm TA (TLIF Articulating)...
Feb 05, 2021 04:05 pm ET
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to nine non-executive employees. The awards...
Jan 20, 2021 04:05 pm ET
SeaSpine Announces Limited Commercial Launch of Regatta® Lateral Plate System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its Regatta Lateral Plate System.  Marking the...
Jan 11, 2021 05:00 am ET
SeaSpine Announces Preliminary Results and Record Quarterly Revenue, Driven by U.S. Sales Channel
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full-year 2020, with...
Dec 15, 2020 08:00 am ET
SeaSpine Announces FDA 510(k) Clearance for Amended Indication for NanoMetalene® Surface Technology
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration...
Dec 07, 2020 08:00 am ET
SeaSpine Announces Limited Commercial Launch of Meridian™ ALIF System with Reef™ A Interbody
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its Meridian ALIF (anterior lumbar interbody...
Dec 02, 2020 04:05 pm ET
SeaSpine Announces Limited Commercial Launch of its Admiral™ ACP System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and subsequent first case of its Admiral ACP...
Nov 09, 2020 04:05 pm ET
SeaSpine Reports Third Quarter 2020 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended September 30, 2020. Summary of...
Nov 04, 2020 04:05 pm ET
SeaSpine to Participate in Three Upcoming Investor Conferences
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in three upcoming virtual investor conferences....
Nov 03, 2020 08:00 am ET
SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the publication of results from a preclinical study, “Examination of the Role of...
Oct 27, 2020 04:05 pm ET
SeaSpine to Report Third Quarter 2020 Financial Results on November 9, 2020
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading...
Oct 06, 2020 04:05 pm ET
SeaSpine Research to Feature at Multiple NASS Podium Presentations
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the following four abstracts involving its products will be presented at...
Oct 06, 2020 08:00 am ET
SeaSpine Provides Preliminary Results for Third Quarter 2020 and Revenue Guidance for Fourth Quarter 2020
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the third quarter of 2020 and provided a...
Oct 02, 2020 05:00 pm ET
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to seventeen non-executive employees. The...
Sep 23, 2020 04:05 pm ET
SeaSpine Announces Limited Commercial Launch of WaveForm C 3D-Printed Interbody Implant System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its WaveForm C Interbody Implant System....
Sep 02, 2020 04:05 pm ET
SeaSpine to Participate in the Cantor Virtual Global Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Cantor Virtual Global Healthcare Conference on...
Aug 27, 2020 04:05 pm ET
SeaSpine Announces Full Commercial Launch of the Shoreline RT® Cervical Interbody Implant System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Shoreline RT Cervical Interbody Implant System....
Aug 27, 2020 04:05 pm ET
SeaSpine will Participate in the Wells Fargo Securities Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Wells Fargo Securities Healthcare Conference on...
Aug 11, 2020 04:05 pm ET
SeaSpine® Announces Limited Commercial Launch of Explorer™ TO Expandable Interbody Device
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of the Explorer™ TO System. Explorer TO represents...
Aug 07, 2020 06:31 pm ET
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to eleven non-executive employees. The...
Aug 04, 2020 04:05 pm ET
SeaSpine Reports Second Quarter 2020 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three months ended June 30, 2020. Summary of Second...
Aug 03, 2020 04:05 pm ET
SeaSpine to Participate in Virtual Fireside Chat at Canaccord Genuity 40th Annual Growth Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in a virtual fireside chat at The Canaccord Genuity...
Jul 22, 2020 04:05 pm ET
SeaSpine to Report Second Quarter 2020 Financial Results on August 4, 2020
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading...
Jun 30, 2020 04:05 pm ET
SeaSpine Announces Full Commercial Launch of Mariner MIS and Mariner Outrigger Spinal Fixation Systems
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launches of Mariner MIS and Mariner Outrigger. “The...
Jun 22, 2020 04:05 pm ET
SeaSpine Announces Limited Commercial Launches of NorthStar™ OCT and Cervical Facet Fusion™ Systems
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launches and completion of initial surgeries of both its...
May 11, 2020 05:44 pm ET
SeaSpine to Participate in a Virtual Fireside Chat with BTIG
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in a virtual fireside chat with BTIG. SeaSpine is...
May 06, 2020 04:03 pm ET
SeaSpine Reports First Quarter 2020 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended March 31, 2020. Summary of First...
May 01, 2020 05:05 pm ET
SeaSpine Announces Time Change for its First Quarter 2020 Earnings Conference Call on May 6, 2020
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced a time change for its first quarter financial results conference call on...
May 01, 2020 07:00 am ET
SeaSpine to Present at the SunTrust Robinson Humphrey (STRH) Life Sciences Summit Virtual Meeting Series
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming STRH Life Sciences Summit Virtual...
Apr 28, 2020 04:53 pm ET
SeaSpine to Provide Business Update and Report First Quarter 2020 Financial Results on May 6, 2020
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will provide a business and operational update and release first quarter...
Apr 06, 2020 07:00 am ET
SeaSpine Provides Preliminary Results for First Quarter 2020 and COVID-19 Related Business Update
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the first quarter of 2020 and a business update...
Apr 03, 2020 04:05 pm ET
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to nine non-executive employees. The awards...
Feb 26, 2020 04:05 pm ET
SeaSpine Announces Fourth Quarter and Full-Year 2019 Results and Reaffirms 2020 Revenue Guidance
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2019 and...
Feb 12, 2020 04:05 pm ET
SeaSpine to Report Fourth Quarter and Full Year 2019 Financial Results on February 26, 2020
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release fourth quarter and full year 2019 financial results after...
Feb 07, 2020 12:00 pm ET
SeaSpine® and 7D Surgical Announce Entry into a Strategic Alliance Agreement to Distribute 7D Surgical’s Flagship Machine-Vision Image Guided Surgery (MvIGS) Platform
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, and 7D Surgical, Inc., a privately-held Toronto-based company developing advanced image guidance...
Feb 03, 2020 04:58 pm ET
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to eight non-executive employees. The...
Jan 07, 2020 08:42 pm ET
SeaSpine Prices Public Offering of Common Stock
SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced...
Jan 07, 2020 04:03 pm ET
SeaSpine Commences Public Offering of Common Stock
SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has commenced an underwritten public...
Jan 07, 2020 04:00 pm ET
SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2019; Reports Record Revenue, Driven by Greater Than 20% U.S. Spinal Implants Growth
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full-year 2019, with U.S...
Dec 30, 2019 04:05 pm ET
SeaSpine Announces Full Commercial Launch of Mariner® Midline Posterior Fixation System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Mariner® Midline Posterior Fixation System....
Dec 18, 2019 08:00 am ET
SeaSpine Announces 25,000th NanoMetalene® Implantation
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the implantation of the 25,000th NanoMetalene® interbody device. NanoMetalene is...
Nov 21, 2019 04:05 pm ET
SeaSpine to Present at the 31st Annual Piper Jaffray Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming Piper Jaffray Healthcare Conference...
Oct 29, 2019 04:05 pm ET
SeaSpine Reports Record Revenue, Driven by 16% U.S. Spinal Implants Growth
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the third quarter ended September 30, 2019. Summary of...
Oct 16, 2019 04:05 pm ET
SeaSpine to Report Third Quarter 2019 Financial Results on October 29, 2019
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter 2019 financial results after the close of...
Sep 24, 2019 04:05 pm ET
SeaSpine® Announces Exclusive Development and Licensing Agreement with restor3D®
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has entered into an exclusive (field-based) development and licensing...
Sep 23, 2019 04:05 pm ET
SeaSpine to Present at the Cantor Global Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming Cantor Global Healthcare Conference...
Sep 12, 2019 04:05 pm ET
SeaSpine to Host Analyst & Investor Event on September 26, 2019
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will host an Analyst & Investor Event in Chicago, Illinois on Thursday,...
Sep 10, 2019 04:05 pm ET
SeaSpine to Present at the Ladenburg Thalmann 2019 Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming 2019 Ladenburg Thalmann Healthcare...
Aug 28, 2019 08:30 am ET
SeaSpine to Present at the 14th Annual Wells Fargo Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming 14th Annual Wells Fargo Healthcare...
Aug 14, 2019 04:05 pm ET
SeaSpine Announces Launch of Mariner® MIS Posterior Fixation System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of initial surgeries of the Mariner®...
Aug 01, 2019 04:05 pm ET
SeaSpine Reports Second Quarter 2019 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended June 30, 2019 and updated its financial...
Aug 01, 2019 08:30 am ET
SeaSpine Announces the Launch of the Shoreline RT™ Cervical Interbody Implant System, featuring Reef Topography™
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of the first surgery for its...
Jul 31, 2019 08:30 am ET
SeaSpine Announces Launch of Mariner® Outrigger® Revision System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the limited commercial launch of the Mariner Outrigger Revision System. Mariner...
Jul 26, 2019 08:30 am ET
SeaSpine Announces 20,000th NanoMetalene® Implantation
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the implantation of the 20,000th NanoMetalene® interbody device. This milestone...
Jul 19, 2019 08:30 am ET
SeaSpine to Report Second Quarter 2019 Financial Results on August 1, 2019
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release second quarter 2019 financial results after the close of...
Jul 18, 2019 08:30 am ET
SeaSpine Announces Portfolio Expansion of OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone Fibers
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the product release of its OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone...
Jul 11, 2019 04:05 pm ET
SeaSpine Announces Full Commercial Launch of Regatta® Lateral System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Regatta® Lateral System, featuring...
May 01, 2019 04:05 pm ET
SeaSpine Reports First Quarter 2019 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended March 31, 2019 and updated its financial...
Apr 18, 2019 04:05 pm ET
SeaSpine to Report First Quarter 2019 Financial Results on May 1, 2019
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release first quarter 2019 financial results after the close of...
Apr 18, 2019 08:15 am ET
New Research: Key Drivers of Growth for SeaSpine, Hallmark Financial Services, Richardson Electronics, Infrastructure and Energy Alternatives, Global Water Resources, and Condor Hospitality Trust — Fa
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of SeaSpine Holdings Corporation (NASDAQ:SPNE), Hallmark Financial...
Apr 12, 2019 02:00 pm ET
Kuros Biosciences Reports Results for the Full Year 2018
Kuros Biosciences successfully delivered on its targets in 2018, realizing first sales of MagnetOs and confirming its successful transition into a fully-fledged orthobiologics company with scientific, clinical, and commercial excellence in bone...
Feb 27, 2019 04:05 pm ET
SeaSpine Announces Fourth Quarter and Full-Year 2018 Results and Reaffirms 2019 Revenue Guidance
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2018 and...
Feb 19, 2019 05:00 pm ET
SeaSpine Appoints Kim Commins-Tzoumakas and Renee Gaeta to its Board of Directors
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Kim Commins-Tzoumakas and Renee Gaeta as members of the...
Feb 14, 2019 07:01 pm ET
SeaSpine to Report Fourth Quarter and Full Year 2018 Financial Results on February 27, 2019
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release fourth quarter and full year 2018 financial results after the...
Feb 11, 2019 01:00 am ET
Kuros Biosciences Signs Agreement to Supply SeaSpine with Bone Graft Incorporating Kuros’s Advanced Submicron Surface Technology
Kuros Biosciences (SIX: KURN) today announced that its Dutch subsidiary, Kuros Biosciences BV, has signed a private label Original Equipment Manufacturer (OEM) agreement with SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology...
Jan 07, 2019 08:30 am ET
SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2018
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full-year 2018....
Nov 21, 2018 04:05 pm ET
SeaSpine to Participate in the 30th Annual Piper Jaffray Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to present at the 30th Annual Piper Jaffray Healthcare...
Nov 19, 2018 09:00 am ET
Report: Developing Opportunities within Command Center, Neurotrope, Selecta Biosciences, InVivo Therapeutics, SeaSpine, and Senestech — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Command Center Inc. (NASDAQ:CCNI), Neurotrope, Inc. (NASDAQ:NTRP),...
Nov 06, 2018 04:05 pm ET
SeaSpine Reports Third Quarter 2018 Financial Results
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended September 30, 2018. Summary Third...
Oct 23, 2018 04:05 pm ET
SeaSpine to Report Third Quarter 2018 Financial Results on November 6, 2018
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release third quarter 2018 financial results after the close of...
Oct 11, 2018 08:57 am ET
SeaSpine Prices Public Offering of Common Stock
SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced...
Oct 10, 2018 04:24 pm ET
SeaSpine Commences Public Offering of Common Stock
SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has commenced an underwritten public...
Oct 02, 2018 08:15 am ET
SeaSpine Announces Preliminary Results for Third Quarter 2018
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the three-months ended September 30, 2018....
Sep 28, 2018 04:05 pm ET
SeaSpine to Present at Upcoming Investor Conferences
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to present at two upcoming investor conferences. SeaSpine...
Sep 26, 2018 08:15 am ET
SeaSpine Announces Launch of Regatta™ Lateral System
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the launch of the Regatta™ Lateral System, featuring NanoMetalene® technology....
Aug 28, 2018 05:15 pm ET
SeaSpine to Participate in the 13th Annual Wells Fargo Securities Healthcare Conference (corrected time)
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in the 13th Annual Wells Fargo Securities...
Aug 28, 2018 04:05 pm ET
SeaSpine to Participate in the 13th Annual Wells Fargo Securities Healthcare Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in the 13th Annual Wells Fargo Securities...
Aug 03, 2018 04:05 pm ET
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to nine non-executive employees. The awards...
Jul 30, 2018 04:05 pm ET
SeaSpine Reports Second Quarter 2018 Financial Results
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended June 30, 2018 and updated its financial...
Jul 16, 2018 04:05 pm ET
SeaSpine to Report Second Quarter 2018 Financial Results on July 30, 2018
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release second quarter 2018 financial results after the close of...
Jul 02, 2018 08:00 am ET
SeaSpine Names Dennis L. Cirino Senior Vice President, Spinal Systems
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has appointed Dennis L. Cirino to the newly created position of Senior...
May 03, 2018 04:05 pm ET
SeaSpine Reports First Quarter 2018 Financial Results
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended March 31, 2018. Summary First Quarter...
Apr 19, 2018 04:30 pm ET
SeaSpine to Report First Quarter 2018 Financial Results on May 3, 2018
CARLSBAD, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release first quarter 2018 financial results...
Mar 07, 2018 04:30 pm ET
SeaSpine to Participate in the 38th Annual Cowen Healthcare Conference
CARLSBAD, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in the Cowen 38th...
Feb 28, 2018 04:05 pm ET
SeaSpine Announces Fourth Quarter and Full-Year 2017 Results and Issues 2018 Financial Guidance
CARLSBAD, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December...
Feb 28, 2018 10:00 am ET
SeaSpine Holdings Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 28, 2018 / SeaSpine Holdings Corp. (NASDAQ: SPNE) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018 at 4:30 PM Eastern Time.
Feb 21, 2018 04:30 pm ET
SeaSpine to Report Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
CARLSBAD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release fourth quarter and full year...
Jan 31, 2018 08:00 am ET
SeaSpine Expands Ventura™ NanoMetalene® Implant Offering to Accommodate Larger Range of Posterior Procedures
CARLSBAD, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the portfolio expansion of the Ventura™ NanoMetalene® posterior interbody...
Jan 08, 2018 08:00 am ET
SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2017
CARLSBAD, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for fourth quarter and full-year 2017. 
Nov 30, 2017 08:30 am ET
SeaSpine Announces FDA 510(k) Clearance of OsteoBallast™ Demineralized Bone Matrix in Resorbable Mesh
CARLSBAD, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has received 510(k) clearance from the United...
Nov 16, 2017 04:15 pm ET
SeaSpine to Participate in the 29th Annual Piper Jaffray Healthcare Conference
CARLSBAD, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in the Piper Jaffray 29th...
Nov 02, 2017 04:03 pm ET
SeaSpine Reports Third Quarter 2017 Financial Results
CARLSBAD, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the third quarter ended September 30, 2017.
Nov 01, 2017 07:42 pm ET
SeaSpine Announces Limited Commercial Launch of OsteoStrand™ Demineralized Bone Fibers
CARLSBAD, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of initial surgeries...
Oct 25, 2017 04:05 pm ET
SeaSpine Announces Preliminary Results for Third Quarter 2017
CARLSBAD, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results at and for the three-months ended September 30, 2017....
Oct 19, 2017 04:15 pm ET
SeaSpine to Report Third Quarter 2017 Financial Results on November 2, 2017
CARLSBAD, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release third quarter 2017 financial results after the close of trading on Thursday, November 2, 2017.  The Company’s management team will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET to discuss the financial results and recent business developments....
Aug 03, 2017 04:05 pm ET
SeaSpine Reports Second Quarter 2017 Financial Results
CARLSBAD, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the second quarter ended June 30, 2017....
Jul 20, 2017 04:30 pm ET
SeaSpine to Report Second Quarter 2017 Financial Results on August 3, 2017
CARLSBAD, Calif., July 20, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release second quarter 2017 financial results after the close of trading on Thursday, August 3, 2017.  The Company’s management team will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET to discuss the financial results and recent business developments....
Jul 13, 2017 04:05 pm ET
SeaSpine Announces Limited Commercial Launch of Skipjack™ Expandable Interbody System
CARLSBAD, Calif., July 13, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of and completion of initial cases for its Skipjack Expandable Interbody System. ...
Jul 11, 2017 06:30 am ET
SeaSpine Announces Preliminary Results for Second Quarter 2017
CARLSBAD, Calif., July 11, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the three-months ended June 30, 2017....
Jul 07, 2017 09:28 am ET
SeaSpine Announces Full Commercial Launch of Mariner Posterior Fixation System
CARLSBAD, Calif., July 07, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of  Mariner® Posterior Fixation System. ...
May 04, 2017 04:05 pm ET
SeaSpine Reports First Quarter 2017 Financial Results
CARLSBAD, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the first quarter ended March 31, 2017....
Apr 21, 2017 04:35 pm ET
SeaSpine to Report First Quarter 2017 Financial Results on May 4, 2017
CARLSBAD, Calif., April 21, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release first quarter 2017 financial results after the close of trading on Thursday, May 4, 2017.  The Company’s management team will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET to discuss the financial results and recent business developments....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.